Novakand Pharma AB (publ)

LARK · ST · Financial Services / Asset Management

2.34SEK+0.05 (+2.18%)

Price History

Full chart

Market Stats

Previous Close2.29

Open2.29

Day Range2.29 – 2.34

52-Week Range1.75 – 2.87

Volume449

Market Cap44.16M

P/E (TTM)37.17

Forward P/E0.00

EPS0.06

Dividend Yield90.50%

Beta1.09

50-Day Avg2.25

200-Day Avg2.23

About

Lärkberget AB (publ) operates as an investment company. The company is involved in direct investments in low-risk instruments, and unlisted profitable companies; financial investments; and reverse acquisition business. It also invests in listed shares, funds and other liquid asset classes, as well as participates in bridge loans and guarantee commitments. The company was formerly known as CombiGene AB (publ) and changed its name to Lärkberget AB (publ) in June 2025. Lärkberget AB (publ) was incorporated in 1990 and is based in Östermalm, Sweden.

Company Details

SectorFinancial Services
IndustryAsset Management
CEOMr. Peter Ekolind
Employees1
HeadquartersAboutvalue, Östermalm, Sweden, 114 34, Sweden
Websitehttps://larkberget.se

Leadership

Mr. Peter EkolindChief Executive Officer · b. 1964
Ms. Annika EricssonChief Scientific Officer

Financials

Income Statement

Currency: SEK	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	-	-	-	-	-	3.00M	8.15K	14.99M	10.83M	84.04M	26.70M	5.54M	326.00K	0
Growth (%)	-	-	-	-	-	-	-99.73%	+183867.59%	-27.75%	+676.15%	-68.23%	-79.24%	-94.12%	-100.00%
Cost of Revenue	-	-	-	-	7.25M	12.41M	15.05M	1.17M	29.64M	68.88M	45.90M	26.84M	47.11M	8.16M
Gross Profit	-	-	-	-	-7.25M	-9.41M	-11.37M	13.82M	8.33M	15.16M	-19.20M	-21.29M	-46.78M	-8.16M
Gross Margin	-	-	-	-	-	-313.60%	-139516.33%	92.22%	76.96%	18.04%	-71.91%	-384.04%	-14349.69%	-
Operating Expense	-	-	-	-	1.42M	-450.00K	1.82M	31.51M	36.49M	-5.80M	-12.25M	17.31M	438.00K	4.81M
Operating Income	-9.76K	-27.48K	-961.00K	-6.25M	-8.67M	-8.96M	-13.18M	-17.69M	-28.16M	20.96M	-6.95M	-38.60M	-47.22M	-12.98M
Operating Margin	-	-	-	-	-	-298.60%	-161809.48%	-118.06%	-260.06%	24.95%	-26.02%	-696.25%	-14484.05%	-
EBITDA	-2.05K	-10	861	2.42K	30	-111	83.69K	-16.52M	-25.66M	23.56M	-5.86M	-35.98M	-34.22M	-7.19M
EBITDA Margin	-	-	-	-	-	-0.00%	1027.40%	-110.27%	-237.02%	28.03%	-21.94%	-648.92%	-10496.93%	-
Net Income	-11.81K	-27.50K	-961.00K	-6.47M	-8.67M	-8.96M	-13.15M	-17.84M	-30.77M	20.96M	-6.16M	-35.66M	-44.88M	-12.36M
Net Income Margin	-	-	-	-	-	-298.60%	-161379.82%	-119.04%	-284.22%	24.95%	-23.06%	-643.31%	-13766.26%	-
Interest Expense	-	-	-	-	91	111	381.16K	237.04K	1.39M	0	1.68K	4.80K	0	83.00K
Interest Expense % of Total Revenue	-	-	-	-	-	0.00%	4679.14%	1.58%	12.86%	0.00%	0.01%	0.09%	0.00%	-

Balance Sheet

Currency: SEK	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	594.67K	639.58K	6.25M	10.96M	4.89M	8.14M	35.12M	43.82M	79.41M	166.22M	158.22M	120.61M	75.88M	56.73M
Total Liabilities	296.58K	40.98K	582.04K	691.73K	809.66K	1.63M	14.66M	23.51M	7.98M	7.94M	6.10M	4.16M	4.30M	1.24M
Total Equity	298.09K	598.60K	5.67M	10.27M	4.08M	6.51M	20.46M	18.46M	71.43M	158.28M	152.12M	116.46M	71.58M	55.49M
Cash	62	12.69K	5.19M	9.38M	3.05M	4.92M	31.80M	13.17M	48.90M	136.74M	131.78M	101.44M	73.75M	2.59M
Total Debt	-	-	-	-	-	-	-	7.00M	-	-	-	-	-	-
Net Debt	-62	-12.69K	-5.19M	-9.38M	-3.05M	-4.92M	-31.80M	-6.17M	-48.90M	-136.74M	-131.78M	-101.44M	-73.75M	-2.59M

Cash Flow

Currency: SEK	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	59.21K	-272.15K	-620.67K	-6.29M	-8.81M	-9.53M	227.60K	-21.60M	-38.35M	22.11M	-16.67M	-30.56M	-29.95M	-12.78M
Investing Cash Flow	-74.28K	-43.22K	-226.49K	-600.40K	-77.30K	-	-430.20K	-1.52M	-3.21M	-147.73K	-	-988.90K	-81.00K	-49.78M
Financing Cash Flow	-	328.00K	6.03M	11.07M	2.48M	11.39M	27.09M	6.49M	75.29M	65.88M	-	-	-	-3.96M
Capital Expenditure	0	0	0	300.40K	77.30K	0	430.20K	0	104.35K	147.73K	0	108.90K	0	0
Free Cash Flow	59.21K	-272.15K	-620.67K	-6.59M	-8.89M	-9.53M	-202.60K	-21.60M	-38.45M	21.97M	-16.67M	-30.67M	-29.95M	-12.78M
Dividends Paid	-	-	-	-	534.32K	-	-	-	-	-	-	-	-	3.96M
FCF to OCF	100.00%	100.00%	100.00%	104.78%	100.88%	100.00%	-89.02%	100.00%	100.27%	99.33%	100.00%	100.36%	100.00%	100.00%
Dividend Paid to FCF	-	-	-	-	-6.01%	-	-	-	-	-	-	-	-	-30.99%

Earnings

Report Date	Jun 30, 2015	Sep 30, 2015	Dec 31, 2015	Mar 31, 2016	Jun 30, 2016	Sep 30, 2016	Mar 31, 2017	Jun 30, 2017	Sep 30, 2017	Dec 31, 2017	Mar 31, 2018	Jun 30, 2018	Sep 30, 2018	Dec 31, 2018	Mar 31, 2019	Jun 30, 2019	Sep 30, 2019	Dec 31, 2019	Mar 31, 2020	Jun 30, 2020	Sep 30, 2020	Dec 31, 2020	Mar 31, 2021	Jun 30, 2021	Sep 30, 2021	Dec 31, 2021	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Mar 31, 2023	Jun 30, 2023	Sep 30, 2023	Dec 31, 2023	May 17, 2024	Aug 23, 2024	Nov 8, 2024	Feb 17, 2025
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	-1.73	-1.25	-2.23	-1.29	-2.13	-2.24	0.20	-2.05	-1.86	-2.17	-1.30	-1.37	-5.79	-1.19	-0.93	-1.06	-1.07	-2.67	-2.26	-0.83	-0.87	-1.18	-0.55	-0.06	-0.62	2.90	-0.14	0.23	0.20	-0.60	-0.74	-0.32	-0.42	-0.32	-0.72	-0.38	-0.45	-0.71
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap44.16M

Enterprise Value40.36M

Trailing P/E37.17

Forward P/E0.00

Price / Sales68.78

Price / Book0.82

EPS0.06

Book Value2.86

Revenue (TTM)642.00K

Gross Profit (TTM)-2.14M

EBITDA-7.19M

Profit Margin187.07%

Operating Margin-2021.00%

Return on Equity2.15%

Return on Assets-2.31%

Shares Outstanding19.80M

Shares Float12.64M

Beta1.09

Dividend Yield90.50%

Dividend Rate2.00

Payout Ratio3581.28%

Dividends

20261×

2.00May 8, 2026

20251×

0.20Jun 13, 2025

Stock Splits

Jun 7, 20211:20